In 2013, North America led the global dialysis products and services market. High prevalence of end stage renal disease, rapid adoption of innovative dialysis products and services, along with the availability of favorable reimbursement policies are driving the North America dialysis products and services market. Although North America holds the largest share in the global market, it is Asia Pacific that is projected to witness the fastest growth in the global dialysis products and services market in the coming few years.

However, the landscape of the Asia Pacific dialysis products and services market is different from that of North America. In North America, companies such as DaVita and Fresenius are dominating the market, but these big players are finding it very difficult to penetrate the Asia Pacific market. Let’s look at the dynamics of the Asia Pacific dialysis products and services market.

According to a recent survey conducted by the China National Survey of Chronic Kidney disease, the prevalence of chronic kidney disease (CKD) in the Chinese population is nearly 11%. CKD is now an important health concern in the country. Approximately 120 million adults in the country have CKD and may need dialysis at some point in their life. The sharp rise in the number of people requiring dialysis in China will propel the Asia Pacific dialysis products and services market substantially.

Other factors that will contribute to the growth of the China dialysis products and services market include the rapid development of the Chinese economy, rising prevalence of hypertension and diabetes, and accelerating investments by the government in healthcare infrastructure. Backed by these trends, China is expected to grow at the fastest rate in the Asia Pacific dialysis products and services market in the foreseeable future.

India is one of the strongest emerging markets in the world. Due to the rapid development in the country and increasing prevalence of Westernized lifestyles, the nation is experiencing an epidemic of diabetes and chronic kidney disease. The number of diabetics in India is projected to be 101 million by 2030, but the cost of dialysis makes it a luxury for the majority of patients in the developing country.

Due to this high demand for dialysis and shortage in supply of affordable dialysis services, several hospitals such as Apollo and Fortis are opening dialysis centers in the country. Fortis plans to open around 50 dialysis clinics in the country in the coming two years. Besides the high demand, rising government subsidies are projected to drive the India dialysis products and services market.

Favorable Government Regulations

Apart from the rising number of diabetes and CKD cases in countries in Asia Pacific such as India and China, favorable government regulations will also boost the market. In Asia Pacific, the majority of dialysis centers are run by state-owned medical institutions.

Hence, the share of aforementioned giants such as DaVita and Fresenius in the hemodialysis services sector in Asia Pacific is quite low compared to that in North America. The impact of government policies will continue to restrain international companies in the Asia Pacific dialysis products and services market in the coming few years.